BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barber KE, King ST, Stover KR, Pogue JM. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Review of Anti-infective Therapy 2014;13:363-77. [DOI: 10.1586/14787210.2015.1001839] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Gargvanshi S, Gutheil WG. Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium. Microbiol Spectr 2022;:e0141222. [PMID: 35969069 DOI: 10.1128/spectrum.01412-22] [Reference Citation Analysis]
2 Mohanty S, Behera B. Antibiogram Pattern and Virulence Trait Characterization of Enterococcus Species Clinical Isolates in Eastern India: A Recent Analysis. J Lab Physicians. [DOI: 10.1055/s-0042-1750085] [Reference Citation Analysis]
3 de Oliveira Santos JV, da Costa Júnior SD, de Fátima Ramos Dos Santos Medeiros SM, Cavalcanti IDL, de Souza JB, Coriolano DL, da Silva WRC, Alves MHME, Cavalcanti IMF. Panorama of Bacterial Infections Caused by Epidemic Resistant Strains. Curr Microbiol 2022;79:175. [PMID: 35488983 DOI: 10.1007/s00284-022-02875-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Barber KE, Shammout Z, Smith JR, Kebriaei R, Morrisette T, Rybak MJ. Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis. Antibiotics (Basel) 2021;10:897. [PMID: 34438947 DOI: 10.3390/antibiotics10080897] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Gargvanshi S, Vemula H, Gutheil WG. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium. J Bacteriol 2021;203:e0023021. [PMID: 34060906 DOI: 10.1128/JB.00230-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Song X, Zeng M, Wu Y, Pan Y. Competence Mining of Vancomycin (VAN) in the Management of Infections Due to Bacterial Strains With High VAN Minimum Inhibitory Concentrations (MICs): A Novel Dosing Strategy Based on Pharmacokinetic/Pharmacodynamic Modeling. Front Microbiol 2021;12:649757. [PMID: 33967986 DOI: 10.3389/fmicb.2021.649757] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 El-Gendy AO, Brede DA, Essam TM, Amin MA, Ahmed SH, Holo H, Nes IF, Shamikh YI. Purification and characterization of bacteriocins-like inhibitory substances from food isolated Enterococcus faecalis OS13 with activity against nosocomial enterococci. Sci Rep 2021;11:3795. [PMID: 33589735 DOI: 10.1038/s41598-021-83357-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Shi C, Jin W, Xie Y, Zhou D, Xu S, Li Q, Lin N. Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2020;21:235-45. [DOI: 10.1016/j.jgar.2019.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zou Z, Sun J, Li Q, Pu Y, Liu J, Sun R, Wang L, Jiang T. Vancomycin modified copper sulfide nanoparticles for photokilling of vancomycin-resistant enterococci bacteria. Colloids Surf B Biointerfaces 2020;189:110875. [PMID: 32087532 DOI: 10.1016/j.colsurfb.2020.110875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Antonello RM, D'oria M, Cavallaro M, Dore F, Cova MA, Ricciardi MC, Comar M, Campisciano G, Lepidi S, De Martino RR, Chiarandini S, Luzzati R, Di Bella S. Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update. Journal of Infection and Chemotherapy 2019;25:669-80. [DOI: 10.1016/j.jiac.2019.05.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
11 Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, Hammerum AM, Schaffer K, Burns K, Murchan S, Novais C, Freitas AR, Peixe L, Del Grosso M, Pantosti A, Werner G. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Drug Resistance Updates 2018;40:25-39. [DOI: 10.1016/j.drup.2018.10.002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 92] [Article Influence: 18.8] [Reference Citation Analysis]
12 Maraolo AE, Gentile I, Pinchera B, Nappa S, Borgia G. Current and emerging pharmacotherapy for the treatment of bacterial peritonitis. Expert Opin Pharmacother 2018;19:1317-25. [PMID: 30071176 DOI: 10.1080/14656566.2018.1505867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens. J Infect Chemother 2018;24:237-46. [PMID: 29396199 DOI: 10.1016/j.jiac.2018.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
14 Isenman H, Fisher D. Advances in prevention and treatment of vancomycin-resistant Enterococcus infection. Curr Opin Infect Dis 2016;29:577-82. [PMID: 27584589 DOI: 10.1097/QCO.0000000000000311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
15 Benamu E, Deresinski S. Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention. F1000Res 2018;7:3. [PMID: 29333263 DOI: 10.12688/f1000research.11831.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zhou Z, Peng S, Sui M, Chen S, Huang L, Xu H, Jiang T. Multifunctional nanocomplex for surface-enhanced Raman scattering imaging and near-infrared photodynamic antimicrobial therapy of vancomycin-resistant bacteria. Colloids and Surfaces B: Biointerfaces 2018;161:394-402. [DOI: 10.1016/j.colsurfb.2017.11.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
17 Brasg I, Elligsen M, MacFadden D, Daneman N. Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort study. CMAJ Open 2017;5:E632-7. [PMID: 28814382 DOI: 10.9778/cmajo.20170034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J; Spanish Society of Transplantation (SET)., Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC)., Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016). Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev (Orlando) 2018;32:36-57. [PMID: 28811074 DOI: 10.1016/j.trre.2017.07.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
19 Zhang Y, Du M, Chang Y, Chen LA, Zhang Q. Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study. Antimicrob Resist Infect Control 2017;6:73. [PMID: 28680588 DOI: 10.1186/s13756-017-0231-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
20 van Harten RM, Willems RJL, Martin NI, Hendrickx APA. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies? Trends Microbiol 2017;25:467-79. [PMID: 28209400 DOI: 10.1016/j.tim.2017.01.004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
21 Tatarelli P, Mikulska M. Multidrug-resistant bacteria in hematology patients: emerging threats. Future Microbiol 2016;11:767-80. [PMID: 27196948 DOI: 10.2217/fmb-2015-0014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
22 Tatarkiewicz J, Staniszewska A, Bujalska-Zadrożny M. New agents approved for treatment of acute staphylococcal skin infections. Arch Med Sci 2016;12:1327-36. [PMID: 27904526 DOI: 10.5114/aoms.2016.59838] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
23 Balletto E, Mikulska M. Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients. Mediterr J Hematol Infect Dis 2015;7:e2015045. [PMID: 26185610 DOI: 10.4084/MJHID.2015.045] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]